An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer
Public ClinicalTrials.gov record NCT00738699. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double Blind, Placebo-Controlled Study of the Efficacy and Safety oF MORAb-003(Farletuzumab) in Combination With Paclitaxel Therapy in Subjects With Platinum-Resistant or Refractory Relapsed Ovarian Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is being conducted to find out if paclitaxel works better when given together with an experimental drug called MORAb-003 (farletuzumab) or alone in patients with platinum-resistant or refractory relapsed ovarian cancer
Study identification
- NCT ID
- NCT00738699
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 415 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2008 (Type not available)
- Primary completion
- Dec 2011 (Actual)
- Completion
- Jan 2012 (Actual)
- Last update posted
- Mar 30, 2017
2008 – 2012
United States locations
- U.S. sites
- 34
- U.S. states
- 20
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southern Cancer Center | Mobile | Alabama | 36608 | — |
| St. Joseph's Hospital and Medical Center | Phoenix | Arizona | 85013 | — |
| California Cancer Care, Inc. | Greenbrae | California | 94904 | — |
| Moores UC San Diego Cancer Center | La Jolla | California | 92093 | — |
| USC/Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | — |
| Monterey Bay Oncology | Monterey | California | 93940 | — |
| Jupiter Medical Center | Jupiter | Florida | 33458 | — |
| Innovative Medical Research of South Florida, Inc. | Miami | Florida | 33179 | — |
| Florida Hospital Cancer Institute | Orlando | Florida | 32804 | — |
| Sarasota Memorial Hospital | Sarasota | Florida | 34239 | — |
| Memorial Health University Medical Center | Savannah | Georgia | 31404 | — |
| Central DuPage Hospital | Winfield | Illinois | 60190 | — |
| St. Vincent Gynecologic Oncology | Indianapolis | Indiana | 46260 | — |
| Hematology and Oncology Specialists, LLC | Metairie | Louisiana | 70006 | — |
| Johns Hopkins Hospital | Baltimore | Maryland | 21231 | — |
| Weinberg Cancer Institute at Franklin Square | Baltimore | Maryland | 21237 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Morristown Memorial Hospital | Morristown | New Jersey | 07962 | — |
| Schwartz Gynecologic Oncology, PLLC | Brightwaters | New York | 11718 | — |
| Arena Oncology Associates, PC | Lake Success | New York | 11042 | — |
| St. Luke's Roosevelt Hospital Center | New York | New York | 10019 | — |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10065 | — |
| Piedmont Hematology Oncology Associates, PA | Winston-Salem | North Carolina | 27103 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Signal Point Clinical Research Center | Middletown | Ohio | 45042 | — |
| Cancer Care Associates | Tulsa | Oklahoma | 74136 | — |
| Abington Memorial Hospital | Abington | Pennsylvania | 19001 | — |
| Magee-Women's Hospital of UPMC | Pittsburgh | Pennsylvania | 15213 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| International Beneficence Clinical Research, LLC | Harlingen | Texas | 78550 | — |
| South Texas Oncology & Hematology PA | San Antonio | Texas | 78229 | — |
| Scott & White Memorial Hospital and Clinic | Temple | Texas | 76508 | — |
| Utah Cancer Specialists | Salt Lake City | Utah | 84106 | — |
| Northern Virginia Pelvic Surgery Associates | Annandale | Virginia | 22003 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00738699, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 30, 2017 · Synced Nov 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00738699 live on ClinicalTrials.gov.